Penny stocks are incredibly dangerous investments that can burn new and seasoned investors alike. InvestorPlace’s best micro-cap analysts recommend buying penny stocks, or cheap stocks, only with the strictest of warnings. But while pink sheet stocks can be halved in the blink of an eye, they can also double much quicker than large-cap stocks.
Penny Stocks
Stay Far Away From the Naked Brand Pump
NAKD stock has soared on the back of the Reddit trade. And while the company has taken advantage, the case for Naked Brand remains far too weak.
Despite Market Over-Enthusiasm, Zomedica Is Worth Real Consideration
Zomedica just raised approximately $200 million from a bought deal. Loaded with cash, ZOM stock look ready to move higher.
Jaguar Health Has Promise, But It’s Not a Good Investment Yet
JAGX stock needs to prove the effectiveness of its drug candidates before investors can consider jumping on its bandwagon.
Naked Brand Cleaned Up Its Balance Sheet With a New Business Model
Naked Brand cleaned up its balance sheet with a new business model. NAKD stock is at best fairly valued despite the new balance sheet.
Revenue Growth Makes Supreme Cannabis Stock an Attractive Pot-Sector Play
SPRWF stock is speculative, no doubt, but if you're willing to accept the risks of a low-priced pot stock, then this one's worth considering.
Sundial Is Still Not a Great Buy on the Pullback
With an unclear path to profitability, SNDL stock still has a lot to prove before investors can jump aboard this stock for the long haul.
Jaguar Health Has a Strong Outline, But the Story Is Unclear
The 12-month, 300% gain with JAGX stock has a lot of headline news. There’s a lot to like, but will Jaguar be able to build on its gains?
Zomedica Stock Could Rise Even Higher, But It’s Still a Gamble
Bottom line: there's only call for ZOM stock: be careful, even if shares pull back from here.
Use the Wait-and-See Approach With Zomedica Stock
ZOM stock has a lot of potential for posting major gains in the near term, but pet care play Zomedica needs to make an good first impression.
Why Sundial’s Parabolic Rise May Not Last
In the cannabis space, SNDL stock has soared of late. Here's why the company's astronomical rise might be short-lived.
Sundial Stock Can Easily Double From Current Levels
SNDL stock will continue to trend higher as Sundial Growers ramps up growth initiatives with an increasingly robust cash buffer.
Here’s Why Zomedica Stock Is Less Speculative Than You Might Think
ZOM stock is a speculative buy for several reasons including leaning into a solid, growing market. Now all investors need to wait for is a product.
Zomedica Has More Than Just ‘Tiger King’ Hype to Boost Shares
ZOM stock surged due to a surprising social media endorsement. However, Zomedica has a real commercial product to launch as well.
Ideanomics Offers Exposure to Multiple Sectors of Interest
Could IDEX stock turn out to be a long-term compounder? It's possible as Ideanomics is involved with some interesting niche sectors.
